Fundraising FoxRapid Myco
Belfast, GB · 1 known investors
Find your way into Rapid Myco
Sign up to see every warm intro you have to Rapid Myco
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rapid Myco team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rapid-myco Technologies develops bacteriophage-based diagnostic tests for detecting mycobacterial infections in humans and livestock, with rapid turnaround times. The company offers tests for diseases including Johne's disease in livestock and tuberculosis in humans and animals.
Founders & leadership
AC
Ashley CooperCEOAshley Cooper is CEO of Rapid Myco, which develops bacteriophage-based diagnostic tests for mycobacterial infections in livestock and humans. With over 35 years in life sciences, Cooper has held senior roles across animal health, veterinary diagnostics, pharmaceuticals, and biotech, and has founded 14 university spin-out companies as CEO.
PI
Prof. Irene GrantCSO
Investors · 1
Frequently asked questions
- What does Rapid Myco do?
- Rapid-myco Technologies develops bacteriophage-based diagnostic tests for detecting mycobacterial infections in humans and livestock, with rapid turnaround times. The company offers tests for diseases including Johne's disease in livestock and tuberculosis in humans and animals.
- Who are Rapid Myco's investors?
- Rapid Myco's investors include Clarendon Fund Managers Ltd..
- Where is Rapid Myco headquartered?
- Rapid Myco is headquartered in Belfast, GB.